Production (Stage)
Pacific Biosciences of California, Inc.
PACB
$1.14
$0.1414.00%
NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
P/E (TTM)
--
EPS (TTM)
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -121.54% | -1.02% | -27.54% | -25.43% | 7.44% |
| Total Depreciation and Amortization | 1,116.84% | 101.07% | 179.17% | 138.26% | 92.90% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 35.91% | 13.80% | 94.05% | 56.07% | -33.97% |
| Change in Net Operating Assets | 57.22% | 31.17% | 0.38% | 11.67% | 43.08% |
| Cash from Operations | 27.37% | 20.49% | 11.14% | 2.83% | 13.88% |
| Capital Expenditure | 58.92% | 30.02% | 43.74% | 45.55% | 46.53% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | 100.00% | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 297.27% | 860.90% | -96.46% | 1,142.54% | 184.68% |
| Cash from Investing | 372.73% | 2,593.40% | -100.53% | 693.08% | 2,812.73% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -2,803.81% | -2,651.90% | 48.77% | 18.75% | -3.40% |
| Issuance of Common Stock | -81.50% | -96.23% | -95.78% | -93.92% | -92.59% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 46.47% | 46.47% | -602.07% | -1,171.94% | -- |
| Cash from Financing | 40.93% | -139.48% | -138.88% | -138.92% | -140.19% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 93.29% | 14.17% | -481.80% | -8.42% | -260.63% |